The Drug Enforcement Administration has issued an Immediate Suspension Order to A+ Pharmacy in Chattanooga, Tenn., suspending the retail drugstore’s authority to handle controlled substances.
The action follows a joint investigation with the Tennessee Board of Pharmacy that identified violations of the Controlled Substances Act and compliance discrepancies, according to an April 6 news release from the agency.
The DEA issues Immediate Suspension Orders when it determines there is an imminent danger to public health or safety. A+ Pharmacy is prohibited from handling controlled substances while the suspension remains in effect.
DEA registrants have 30 days to request a hearing, though the suspension remains active during administrative proceedings.
The case is being investigated by the DEA’s Knoxville District Office and the Tennessee Board of Pharmacy.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
